Gene · 3872
Papers3,832
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,832
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling Transcriptome Profile, Epigenetic Dynamics, and Morphological Changes in Psoriasis-like Keratinocytes: "Insights into Similarity with Psoriatic Lesional Epidermis". | Cells | 2023 | 38132145 | PubTator, text mining | PubMed |
| Targeted therapies in bladder cancer: signaling pathways, applications, and challenges. | MedComm (2020) | 2023 | 38107059 | PubTator, text mining | PubMed |
| Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma. | Elife | 2023 | 38099574 | PubTator, text mining | PubMed |
| USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity. | Mol Cancer | 2023 | 38093367 | PubTator, text mining | PubMed |
| Bioinformatics analysis of human kallikrein 5 (KLK5) expression in metaplastic triple-negative breast cancer. | Cancer Innov | 2023 | 38090381 | PubTator, text mining | PubMed |
| Genetic Studies of Actinic Keratosis Development: Where Are We Now? | Ann Dermatol | 2023 | 38086352 | PubTator, text mining | PubMed |
| Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19. | Res Sq | 2023 | 38077031 | PubTator, text mining | PubMed |
| Single cell multi-omics reveal intra-cell-line heterogeneity across human cancer cell lines. | Nat Commun | 2023 | 38071219 | PubTator, text mining | PubMed |
| Influence of Organ Culture on the Characteristics of the Human Limbal Stem Cell Niche. | Int J Mol Sci | 2023 | 38069177 | PubTator, text mining | PubMed |
| Medication-Related Osteonecrosis of the Jaw: A Systematic Review and a Bioinformatic Analysis. | Int J Mol Sci | 2023 | 38069068 | PubTator, text mining | PubMed |
| Breast Cancer Treatment: To tARget or Not? That Is the Question. | Cancers (Basel) | 2023 | 38067367 | PubTator, text mining | PubMed |
| The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target. | Commun Biol | 2023 | 38062202 | PubTator, text mining | PubMed |
| Systemically administered wound-homing peptide accelerates wound healing by modulating syndecan-4 function. | Nat Commun | 2023 | 38057316 | PubTator, text mining | PubMed |
| Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics. | Front Pharmacol | 2023 | 38044943 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of corneal organoids during development. | Stem Cell Reports | 2023 | 38039970 | PubTator, text mining | PubMed |
| Transcriptome profiling of human col\onic cells exposed to the gut pathobiont Streptococcus gallolyticus subsp. gallolyticus. | PLoS One | 2023 | 38033043 | PubTator, text mining | PubMed |
| ΔNp63α facilitates proliferation and migration, and modulates the chromatin landscape in intrahepatic cholangiocarcinoma cells. | Cell Death Dis | 2023 | 38012140 | PubTator, text mining | PubMed |
| Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. | Proc Natl Acad Sci U S A | 2023 | 38011564 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapies for psoriasis. | Signal Transduct Target Ther | 2023 | 38008779 | PubTator, text mining | PubMed |
| Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 Pathway activation and attenuating inflammatory signaling. | Cell Death Dis | 2023 | 38007430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3872/papers?page=16